Trial intelligence / Profile preview

Washed Microbiota Transplantation for ASD

NCT06030752Phase 1Recruiting

Sponsor
The Second Affiliated Hospital of Nanjing Medical University
Start
Sep 2023
Primary completion
Apr 2027
Modality
Live Biotherapeutic Products
Countries
1
01

Overview

Phase 1, open-label, single-arm trial of washed microbiota transplantation in Autism Spectrum Disorder (ASD), sponsored by The Second Affiliated Hospital of Nanjing Medical University. Primary endpoints: Autism Behavior Checklist at 6 months and Autism Treatment Evaluation Checklist at 6 months. Started Sep 2023; status: recruiting.

02

Drugs

washed microbiota transplantation
03

Conditions

Autism Spectrum Disorder (ASD)

Beyond the preview

Go deeper on NCT06030752.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06030752.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call